Regencell Bioscience Holdings LClose $27.39EOD only
Max Pain
$35.00
Next expiry Jun 18, 2026
Expected Move
±$6.55
23.9% from close
Price Gap
+7.61
Distance to max pain
IV Rank
2
Low premium
P/C OI
1.07
Balanced positioning
Consensus
—
No reports available
Published snapshot: May 20, 2026 close
End-of-day snapshot
This page reflects RGC options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.
Published Snapshot
May 20, 2026 close
Exp. Move WideMax Pain AboveGEX Positive
DEX LongIV LowNet Put Premium
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
Expiration
DTE
Expected Move
Move %
Lower
Upper
2026-06-18
29
±$6.55
±23.9%
$20.84
$33.94
2026-07-17
58
±$12.50
±45.6%
$14.89
$39.89
2026-09-18
121
±$12.35
±45.1%
$15.04
$39.74
2026-12-18
212
±$15.05
±55.0%
$12.34
$42.44
RGC Quick Anchors
Strongest Signal
Exp. Move Wide
Total GEX
$0.00B
Total DEX
$0.1M
Expected Move
±23.9%
Put/Call OI
1.07
Near Max Pain
$35.00
Flow Tilt
Put-heavy $-318K
Spot Price
$27.39
How to Use This Overview
This page compresses the latest market-close snapshot into one high-level decision surface.
What it summarizes
Overview pulls the main options context into one place: dealer positioning, volatility, expected move, max pain, and current report coverage.
Where traders usually go next
Use the chain when you need contract selection, dealer exposure when you want positioning context, and reports when you want a structured setup with entry and risk context.
What to remember
This is a market-close snapshot, so the hierarchy can drift intraday when spot, IV, or headline risk moves quickly.
Treat this page like a map of the close, not a live execution dashboard.